Why AMD Stock Is Tumbling Despite Better-Than-Expected Results

Advanced Micro Devices (AMD) reported better-than-anticipated Q2 sales and provided a strong Q3 outlook, yet its shares declined due to high pre-report expectations and a significant prior run-up. The positive guidance notably excluded potential sales of its MI308 AI chip to China, which analysts view as a substantial future upside catalyst as export license reviews resume. Despite the initial stock dip, analysts generally maintain a positive view on AMD's underlying business strength, particularly in data center GPUs.

Analysis

Advanced Micro Devices (AMD) presented a case of fundamental strength clashing with elevated market expectations. The company reported second-quarter sales that surpassed estimates and issued a third-quarter outlook that was also above consensus, yet its stock fell nearly 7%. This decline is largely attributable to the stock's significant run-up of approximately 80% in the preceding months, which set a high bar for the earnings release. According to Citigroup, the guidance for the AI chip business was merely in line with 'Buyside expectations,' failing to provide the substantial beat needed to propel the stock higher. The company's results were bolstered by its gaming segment, though earnings and margins were negatively impacted by an $800 million charge related to China sales restrictions. Critically, AMD's forecast for double-digit revenue growth, driven by its next-generation MI355X AI chip, excludes any potential sales of its China-specific MI308 chip. Analysts at Bank of America and Wedbush view this omission as a source of significant potential upside, noting that AMD's core business outlook appears to be about $500 million stronger than pre-ban consensus, even before accounting for any resumed China sales. This suggests the recent share price weakness is a reaction to sentiment and positioning rather than a signal of business deterioration.

Key Decisions for Investors

• Consider the recent share price decline as a potential entry point, recognizing it reflects a 'sell-the-news' event on a highly-anticipated report rather than a deterioration in the company's fundamental outlook.
• Closely monitor for any U.S. Commerce Department approvals regarding export licenses for the MI308 chip, as this represents a significant, un-guided revenue catalyst for the second half of the year.
• Evaluate AMD's valuation based on its strengthening core operations, particularly the ramp-up of the MI355X AI chip, which underpins a robust growth forecast independent of the uncertain China sales.